Cislini Jeff sold RVMD
December 16, 2025 · Form 4 insider transaction
Cislini Jeff sold 2,688 shares of Revolution Medicines, Inc. at $76.82 per share, a transaction worth $206.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,688
Price
$76.82
Total value
$206.5K
InsiderCislini Jeff
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 16, 2025
Filing dateDecember 18, 2025
Shares owned after47,884
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.; Includes 147 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2025.; Includes 38,769 restricted stock units.